uniQure (QURE) CMO auto-sells shares for RSU tax withholding, keeps stake

Rhea-AI Filing Summary

uniQure N.V. Chief Medical Officer Walid Abi-Saab reported an open-market sale of 1,434 ordinary shares at a weighted average price of $46.86 per share. The shares were sold automatically upon vesting of restricted share units solely to cover estimated withholding taxes, and were not a discretionary trade. Following this transaction, he holds 168,235 shares directly.

Insider Trade Summary

Net Seller: 1,434 shares ($67,197)

Net Sell 1 txn

Insider Abi-Saab Walid

Role Chief Medical Officer

Sold 1,434 shs ($67K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	1,434	$46.86	$67K

Holdings After Transaction: Ordinary Shares — 168,235 shares (Direct, null)

Footnotes (1)

1. The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.69 to $46.96. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 1,434 shares Weighted average sale price: $46.86 per share Post-transaction holdings: 168,235 shares +1 more

4 metrics

Shares sold 1,434 shares Open-market sale linked to RSU vesting

Weighted average sale price $46.86 per share Ordinary shares sale on 2026-06-26

Post-transaction holdings 168,235 shares Direct ownership after transaction

Sale price range $46.69–$46.96 per share Multiple transactions within this range

Key Terms

restricted share units, weighted average price, estimated withholding taxes, automatic sale instructions

4 terms

restricted share units financial

"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

weighted average price financial

"The price reported in Column 4 is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

estimated withholding taxes financial

"solely to cover estimated withholding taxes, pursuant to automatic sale instructions"

automatic sale instructions financial

"pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/30/2026 - 05:07 PM Accepted by SEC EDGAR 06/30/2026 - 05:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Abi-Saab Walid

(Last) (First) (Middle)

C/O UNIQURE N.V.

PAASHEUVELWEG 25A

(Street)

AMSTERDAM 1105BP

(City) (State) (Zip)

NETHERLANDS

(Country)

2. Issuer Name and Ticker or Trading Symbol
uniQure N.V. [ QURE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/26/2026		S(1)		1,434(1)	D	$46.86(2)	168,235	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.69 to $46.96. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Christian Klemt, Attorney-in-Fact	06/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did uniQure (QURE) disclose in Walid Abi-Saab's latest Form 4?

uniQure reported that Chief Medical Officer Walid Abi-Saab sold 1,434 ordinary shares. The transaction was linked to the vesting of restricted share units and executed automatically to cover estimated tax withholding obligations, rather than as a discretionary market sale by the executive.

How many uniQure (QURE) shares did Walid Abi-Saab sell and at what price?

Walid Abi-Saab sold 1,434 uniQure ordinary shares at a weighted average price of $46.86. The footnotes state these shares were sold in multiple trades with prices ranging between $46.69 and $46.96, as part of an automatic sale mechanism tied to RSU vesting.

Why were Walid Abi-Saab's uniQure (QURE) shares sold according to the Form 4?

The shares were sold solely to cover estimated withholding taxes triggered by the vesting of restricted share units. The Form 4 notes the sale followed automatic instructions in the Restricted Share Unit Agreement and was not a discretionary trade initiated by Walid Abi-Saab in the open market.

How many uniQure (QURE) shares does Walid Abi-Saab hold after this Form 4 transaction?

After the reported tax-related sale, Walid Abi-Saab directly holds 168,235 uniQure ordinary shares. This post-transaction balance indicates the sale represented a small portion of his overall stake, primarily addressing tax obligations from the vesting of equity awards.

Were Walid Abi-Saab’s uniQure (QURE) share sales discretionary market trades?

No. The Form 4 footnotes specify the sales occurred automatically under instructions in the Restricted Share Unit Agreement. They were executed upon RSU vesting solely to satisfy estimated withholding taxes, meaning they were not discretionary timing decisions by the executive.